A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379

NCT06204107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: CKD-379(Empagliflozin+sitagliptin+metformin) Test drug
DRUG: CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug

Sponsor

Chong Kun Dang Pharmaceutical